Cargando…
Safety and efficacy of liposomal amphotericin B for the empirical therapy of invasive fungal infections in immunocompromised patients
Liposomal amphotericin B is a “true” liposomal formulation of amphotericin B with greatly reduced nephrotoxicity and minimal infusion-related toxicity. This broad spectrum polyene is well tolerated and effective against most invasive fungal infections. In view of the current limitations on diagnosti...
Autores principales: | Miceli, Marisa H, Chandrasekar, Pranatharthi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3269132/ https://www.ncbi.nlm.nih.gov/pubmed/22294858 http://dx.doi.org/10.2147/IDR.S22587 |
Ejemplares similares
-
Pharmacoeconomic evaluation of voriconazole vs. liposomal amphotericin B in empiric treatment of invasive fungal infections in Turkey
por: Turner, Stuart J, et al.
Publicado: (2013) -
Amphotericin B lipid complex: treatment of invasive fungal infections in patients refractory to or intolerant of amphotericin B deoxycholate
por: Chandrasekar, PH
Publicado: (2008) -
Combination liposomal amphotericin B, posaconazole and oral amphotericin B for treatment of gastrointestinal Mucorales in an immunocompromised patient
por: Anderson, Anthony, et al.
Publicado: (2017) -
Outpatient parenteral antifungal therapy (OPAT) for invasive fungal infections with intermittent dosing of liposomal amphotericin B
por: van de Peppel, Robert J, et al.
Publicado: (2020) -
Economic evaluation of caspofungin vs liposomal amphotericin B for empirical therapy of suspected systemic fungal infection in the German hospital setting
por: Kaskel, Peter, et al.
Publicado: (2007)